A phylogenetic study of traditional plant remedies could aid drug development.
The Scientist
Most Recent
The brain’s phagocytes follow an ATP bread trail laid down by calcium waves to the site of damage.
A human trial of a hepatitis C treatment is shut down after one of the participants died.
The market for drugs that target rare diseases is expected to rival big pharma blockbusters in the coming decades.
A small molecule that inhibits a protein important for chromatin organization can cause reversible sterility in male mice.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Two medical professors contend that the pharmaceutical industry is really suffering from a drive to make only marginal improvements to existing drugs.
Researchers track tumors as they develop, providing more support for the idea that cells with stem-cell-like properties underlie cancer growth and recurrence.
Lymphatic vessels grow towards two chemokines, revealing signals that could be important in cancer metastasis.
Japanese astronauts deliver an aquarium to the International Space Station to study the effects of microgravity on marine life.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
